Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can eye movements in VR reveal mental health conditions?

NCT ID NCT07057024

Diagnosis Sponsor: Etablissement Public de Santé Barthélemy Durand Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study explores whether eye-tracking technology in a virtual reality headset can help identify schizophrenia, bipolar disorder, and depression. Researchers will compare eye movement patterns of 120 participants (including healthy controls) to find specific markers for each condition. The goal is to develop a faster, more reliable diagnostic tool for these psychiatric disorders.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 120 people

The number the study aims to enrol. It can still change while the study runs.

Started

Feb 2026

Expected to finish

Feb 2029

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 60 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: For all participants: * Male or female, aged 18 to 60 years * Subject having given their written consent to the study For Schizophrenia participants : * Diagnosis of schizophrenia according to DSM-V criteria and stabilised for at least three months For bipolar disorder participants : \- Diagnosis of bipolar disorders according to DSM-V criteria and stabilised for at least three months For depressive disorders participants : \- Diagnosis of depressive disorders according to DSM-V criteria and stabilised for at least three months Exclusion Criteria: For all the participants : * Subjects unable to give consent or not volunteering for the study. * Current(s) somatic(s) condition(s) * Specific ophthalmological problems (strabismus, amblyopia) incompatible with the devices stereoscopic (VR headsets) * Head trauma's history with loss of consciousness * Epilepsy history * Intellectual disability * Difficulties in understanding the French language * Current or during the last 6 months of substance abuse or dependence (except tobacco) * Freedom restriction by judicial or administrative decision and/or coercive hospitalisation * Cybersickness history * Pregnancy For healthy control group : * Current or previous psychiatric disorder * Current psychotropic drug therapy

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Depressive disorder are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

bipolar disorder Depression depressive disorder disease psychiatric disorder schizophrenia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Psychiatric disorders (diagnosis)

Contacts and locations

Locations

  • Etablissement Public de Santé Barthélemy Durand

    Étampes, 91 150, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.